Vicarious Surgical (NYSE:RBOT) Price Target Lowered to $7.00 at Piper Sandler

Vicarious Surgical (NYSE:RBOT) had its target price reduced by Piper Sandler from $8.50 to $7.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a neutral rating on the stock.

Vicarious Surgical Stock Performance

Shares of RBOT opened at $7.92 on Wednesday. Vicarious Surgical has a twelve month low of $5.00 and a twelve month high of $19.00. The firm’s 50 day moving average price is $8.75 and its two-hundred day moving average price is $8.87. The firm has a market cap of $46.97 million, a P/E ratio of -0.78 and a beta of 1.41.

Vicarious Surgical (NYSE:RBOT) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($2.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.61) by $0.38. On average, sell-side analysts anticipate that Vicarious Surgical will post -10.89 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Renaissance Technologies LLC raised its holdings in shares of Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after purchasing an additional 1,200 shares during the last quarter. DNB Asset Management AS raised its holdings in shares of Vicarious Surgical by 12.1% in the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after purchasing an additional 3,154 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Vicarious Surgical by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after purchasing an additional 2,336 shares during the last quarter. Finally, DDD Partners LLC raised its holdings in shares of Vicarious Surgical by 15.3% in the first quarter. DDD Partners LLC now owns 213,824 shares of the company’s stock valued at $1,403,000 after purchasing an additional 28,357 shares during the last quarter. Institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.